April 25, 2024 15:35 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Massive landslide hits Arunachal Pradesh, a large section of Highway-33 washed away | Actress Tamannaah Bhatia summoned by Maharashtra cyber cell in 2023 illegal IPL streaming case | Bihar CM Nitish Kumar's party leader shot dead in Patna | Centre moves Supreme Court seeking modification of 2012 verdict in 2G spectrum case | 'Robert Vadra Ab Ki Baar' posters in Amethi as suspense looms over Congress candidate
ISSAR Pharma to out license its peptide-based New Chemical Entities

ISSAR Pharma to out license its peptide-based New Chemical Entities

Hyderabad/IBNS: ISSAR Pharmaceuticals, a leading iIndian pharma company specialising in peptide technology and peptide drug innovation, announced they will license out their peptide-based New Chemical Entities (NCEs), with pre-IND filing and US Patent.